Madrigal Pharmaceuticals, Inc. (MDGL)
NASDAQ·Healthcare·Biotechnology
$392.19
-2.00%
Mkt Cap $9.94B
Analyst Ratings
Buy
7
Hold
1
Sell
0
Price Target (39 analysts)
$677.00
Range $542.00 – $962.00
Implied Upside
+72.6%
Consensus $677.00 vs current $392.19